Axoft is a Cambridge, Massachusetts neurotechnology company developing implantable brain-computer interfaces (iBCIs) built on its proprietary Fleuron material, which is engineered to be roughly 10,000x softer than the polyimide used in conventional neural implants. The company was co-founded in 2021 by Paul Le Floch, Tianyang Ye, and Harvard professor Jia Liu, and has implanted its devices in 11 patients across early clinical studies aimed at improving prognosis and communication for people with neurological disorders. Axoft also commercializes Fleuron for biomedical applications under an exclusive licensing agreement with Stanford University.
1
Round
5
Tags
Apr 29, 2026
Latest raise
Funding activity · 1 round
Apr 29, 2026
$55M
Series A
Led by C.P. Group Innovation
Article coming soon.
Pricing
Public hubs orient you on the raise. Paid plans unlock live AI adoption signals across your market.
For individuals and small teams getting started with AI buyer intelligence.
$149
/month
Features
For outbound teams and agencies that need more coverage and faster signal cadence.
$249
/month
Features
Act on this raise
Funding is the starting point. VeilStrat shows whether capital is showing up as hiring, tools, and web activity you can sell into.
